236 related articles for article (PubMed ID: 29202620)
1. Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer.
Tramm T; Kyndi M; Sørensen FB; Overgaard J; Alsner J
Acta Oncol; 2018 Jan; 57(1):102-106. PubMed ID: 29202620
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.
Batistatou A; Televantou D; Bobos M; Eleftheraki AG; Kouvaras E; Chrisafi S; Koukoulis GK; Malamou-Mitsi V; Fountzilas G
Anticancer Res; 2013 May; 33(5):2139-45. PubMed ID: 23645767
[TBL] [Abstract][Full Text] [Related]
4. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus.
Boone J; van Hillegersberg R; van Diest PJ; Offerhaus GJ; Rinkes IH; Kate FJ
Virchows Arch; 2008 May; 452(5):507-14. PubMed ID: 18392848
[TBL] [Abstract][Full Text] [Related]
5. Validation of tissue microarray biomarker expression of breast carcinomas in Saudi women.
Alkushi A
Hematol Oncol Stem Cell Ther; 2009; 2(3):394-8. PubMed ID: 20139052
[TBL] [Abstract][Full Text] [Related]
6. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
[TBL] [Abstract][Full Text] [Related]
7. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
8. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
[TBL] [Abstract][Full Text] [Related]
10. Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
Gudjónsson S; Bendahl PO; Chebil G; Höglund M; Lindgren D; Lundberg LM; Lövgren K; Fernö M; Månsson W; Liedberg F
Scand J Urol Nephrol; 2011 Sep; 45(4):270-7. PubMed ID: 21504385
[TBL] [Abstract][Full Text] [Related]
11. Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer.
Ciesielska U; Piotrowska A; Kobierzycki C; Pastuszewski W; Podhorska-Okolow M; Dziegiel P; Nowinska K
In Vivo; 2020; 34(6):3263-3270. PubMed ID: 33144432
[TBL] [Abstract][Full Text] [Related]
12. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
Karch I; Schipper E; Christgen H; Kreipe H; Lehmann U; Christgen M
PLoS One; 2013; 8(8):e73062. PubMed ID: 24023670
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
14. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
[TBL] [Abstract][Full Text] [Related]
15. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Varga Z; Cassoly E; Li Q; Oehlschlegel C; Tapia C; Lehr HA; Klingbiel D; Thürlimann B; Ruhstaller T
PLoS One; 2015; 10(4):e0123435. PubMed ID: 25885288
[TBL] [Abstract][Full Text] [Related]
16. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin.
Zarka TA; Han AC; Edelson MI; Rosenblum NG
Int J Gynecol Cancer; 2003; 13(2):240-3. PubMed ID: 12657131
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study.
Nassar A; Radhakrishnan A; Cabrero IA; Cotsonis GA; Cohen C
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):433-41. PubMed ID: 20485156
[TBL] [Abstract][Full Text] [Related]
18. Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
Christgen M; Kandt LD; Antonopoulos W; Bartels S; Van Bockstal MR; Bredt M; Brito MJ; Christgen H; Colpaert C; Cserni B; Cserni G; Daemmrich ME; Danebrock R; Dedeurwaerdere F; van Deurzen CH; Erber R; Fathke C; Feist H; Fiche M; Gonzalez CA; Ter Hoeve ND; Kooreman L; Krech T; Kristiansen G; Kulka J; Laenger F; Lafos M; Lehmann U; Martin-Martinez MD; Mueller S; Pelz E; Raap M; Ravarino A; Reineke-Plaass T; Schaumann N; Schelfhout AM; De Schepper M; Schlue J; Van de Vijver K; Waelput W; Wellmann A; Graeser M; Gluz O; Kuemmel S; Nitz U; Harbeck N; Desmedt C; Floris G; Derksen PW; van Diest PJ; Vincent-Salomon A; Kreipe H
J Pathol Clin Res; 2022 Mar; 8(2):191-205. PubMed ID: 34889530
[TBL] [Abstract][Full Text] [Related]
19. Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.
Kündig P; Giesen C; Jackson H; Bodenmiller B; Papassotirolopus B; Freiberger SN; Aquino C; Opitz L; Varga Z
J Transl Med; 2018 May; 16(1):118. PubMed ID: 29739401
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer.
Visser NCM; van der Wurff AAM; Pijnenborg JMA; Massuger LFAG; Bulten J; Nagtegaal ID
Virchows Arch; 2018 Mar; 472(3):407-413. PubMed ID: 29426961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
